§ Mr. GaleTo ask the Secretary of State for Health if she will list, for each of the last 10 years, the average proportion of the increase in national health service spending attributable to manufacturers' price increases, for each of the 10 groups of prescription medicines and drugs covered by the proposed extension to the limited list.
§ Dr. MawhinneyAvailable data do not permit the effect of manufacturers' pricing increases to be identified separately from other factors affecting the total cost of national health service prescriptions.